
						
							
						
						
							<!--
							google_ad_client = "pub-5806585833518451";
							/* 300x250, created 6/2/09 - iposol_ipo_detail_top */
							google_ad_slot = "4379562531";
							google_ad_width = 300;
							google_ad_height = 250;
									-->
							
							
							
						

						Dr. Lal PathLabs Limited is a Delhi based provider of diagnostic and related healthcare tests and services in India.  Through its nationwide network, company offer patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.Company has built a national network consisting of its National Reference Laboratory in New Delhi, 163 other clinical laboratories, 1,340 patient service centers and over 5,000 pickup points as of March 31, 2015.Company's customers include individual patients, hospitals and other healthcare providers and corporate customers. Highlights:1. Company offers 3,368 diagnostic and related healthcare tests.2. Company collected 21.8 million samples from 9.9 million patients in FY 2015.3. Company is well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry.4. Its centralized information technology platform fully integrates to it network and is scalable.

						
						
							
						
						

						Company Promoters:The Promoters of the company are:1. Dr. Arvind Lal;2. Dr. Vandana Lal; and3. Eskay House

						Company Financials:
	ParticularsFor the year/period ended (in Rs. Million)
	31 Mar 1531 Mar 1431 Mar 1331 Mar 12
	Total Income6,401.175,438.974,238.613,199.03
	Profit After Tax (PAT)879.69739.53488.75410.09


						
							<!--
								google_ad_client = "pub-5806585833518451";
								/* 300x250, created 9/3/09 - IPO Detail Center */
								google_ad_slot = "7910498455";
								google_ad_width = 300;
								google_ad_height = 250;
								-->
							
							
							
						

						Objects of the Issue:The objects of the Offer are:1. To achieve the benefits of listing the Equity Shares on the Stock Exchanges and 2. For the Offer for Sale of up to 11,600,000 Equity Shares.

						Issue Detail:
						  »»  Issue Open: Dec 8, 2015 - Dec 10, 2015
							  »»  Issue Type: Book Built Issue IPO
							  »»  Issue Size: 11,600,000 Equity Shares of Rs 10 aggregating up to Rs 638.00 Cr
							
							
							  »»  Face Value: Rs 10 Per Equity Share
							  »»  Issue Price: Rs. 540 - Rs. 550 Per Equity Share
							  »»  Market Lot: 20 Shares
							  »»  Minimum Order Quantity: 20 Shares
							  »»  Listing At: BSE, NSE
						

						


						
						Dr Lal PathLabs IPO Reviews:
						
							
							Dr. Lal PathLabs Limited IPO review by Dilip Davda
							
						
						


						
							
						

						
							Issue Subscription Detail / Current Bidding StatusNumber of Times Issue is Subscribed (BSE + NSE)As on Date & TimeQIBNIIRIITotalShares Offered / Reserved2,320,0001,740,0004,060,0008,120,000Day 1 - Dec 8, 2015 17:00 IST1.22000.39000.43000.6500Day 2 - Dec 9, 2015 17:00 IST6.13000.57001.56002.6500Day 3 - Dec 10, 2015 23:15 IST63.560061.28004.240033.4100
						
					
